FDA panel votes against wider use of Amgen drug
February 08, 2012
| Reuters
WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to...
FDA panel votes against Xgeva for prostate cancer
February 08, 2012
| AP
A panel of cancer experts has voted against a new use for Amgen's Xgeva in prostate cancer, saying the drug's ability to slow the spread of the disease did not translate into...
FDA question's Amgen drug for prostate cancer
February 06, 2012
| AP
Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to...
New inner- city health center opens in Boston
February 04, 2012
| AP
Bob Thompson learned he had prostate cancer after routine screening at the Whittier Street Health Center, a community-based facility that has long served serving thousands of...
Prostate Cancer Blog Posts
| | | |
Prostate Cancer Related Topics
|
